Medical Lead, UK (Hybrid)

Job Summary

• →Supervise country Medical Affairs staff focused on delivering the medical objectives for the region by providing direction, guidance and oversight of assigned projects and accountabilities
• →Develop and lead the execution of the Medical Affairs strategy at a country level through cross-functional collaboration and influence – supporting efficient go-to-market plans
• →Lead, establish and execute the local medical education plans for the UK: educate HCP with online/in-person blended offerings (on-demand, webinars, Peer-to-Peer training), deliver medical education at congresses and symposiums, support product training with generation and delivery of medical content
• →Inform & strategise evidence generation plans, in answer to fulfil market access, regulatory and marketing needs
• →Support the local execution of Insulet-sponsored and Investigator-Initiated trials
• →Build confidence and advocacy among key external influencers (KOLs)

• Proven leader in Medical Affairs including developing and leading the implementation of medical strategy.
• Excellent written and verbal communication skills in English
• Broad understanding of the international commercial and regulatory environment for medical devices
• Strong scientific acumen and attention to detail
• Combined strategic thinking and execution skills
• Demonstrated ability to integrate, lead and influence in a challenging cross-functional environment.
• High ethical standards which apply to interactions with HCPs, payers, and industry representatives

• Location: London, United Kingdom
• This role will involve frequent travel, approximately 30-40% across the UK and within international region on occasions (conferences, medical education events, internal meetings)

#LI-Hybrid

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.

We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!

Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.